Content block block-customjs
Body
Links in this section relate to Body
Content block block-countyoc-pagetitle-2
Content block block-countyoc-content
Content block block-169629609-1779505949
The following information is from the Centers for Disease Control and Prevention (CDC) Emerging Infectious Diseases: Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States, November 8, 2001, available at: www.cdc.gov/ncidod/eid/vol7no6/jernigan.htm. Additional resources and references are available at www.ochealthinfo.com/epi/bio and at http://www.bt.cdc.gov.
There have been 10 inhalational anthrax patients identified from October 4 to November 2, 2001. The time from exposure to onset of illness (known for 6 of the 10 cases) ranged from 4-6 days with a median of 4 days. Only one of the cases had rhinorrhea.
| Symptom | Number | Symptom | Number |
|---|---|---|---|
|
Fever, chills |
10 |
Myalgias |
6 |
|
Sweats, often drenching |
7 |
Headache |
5 |
|
Fatigue, malaise, lethargy |
10 |
Confusion |
4 |
|
Cough* (minimally or non-productive) |
9 |
Abdominal pain |
3 |
|
Nausea or vomiting |
9 |
Sore throat |
2 |
|
Dyspnea |
8 | Rhinorrhea |
1 |
| Chest discomfort or pleuritic pain | 7 |
*1 case with blood-tinged sputum
Content block block-sociallinksblock